000117953 001__ 117953 000117953 005__ 20230519145554.0 000117953 0247_ $$2doi$$a10.1136/bmjopen-2021-054286 000117953 0248_ $$2sideral$$a128019 000117953 037__ $$aART-2021-128019 000117953 041__ $$aeng 000117953 100__ $$0(orcid)0000-0002-7293-318X$$aOsma, J$$uUniversidad de Zaragoza 000117953 245__ $$aImplementation, efficacy and cost effectiveness of the unified protocol in a blended format for the transdiagnostic treatment of emotional disorders: a study protocol for a multicentre, randomised, superiority controlled trial in the Spanish National Health System 000117953 260__ $$c2021 000117953 5060_ $$aAccess copy available to the general public$$fUnrestricted 000117953 5203_ $$aIntroduction Emotional disorders (EDs) have become the most prevalent psychological disorders in the general population, which has boosted the economic burden associated with their management. Approximately half of the individuals do not receive adequate treatment. Consequently, finding solutions to deliver cost-effective treatments for EDs has become a key goal of today''s clinical psychology. Blended treatments, a combination of face-to-face and online interventions, have emerged as a potential solution to the previous. The Unified Protocol for the Transdiagnostic Treatment of EDs (UP) might serve this purpose, as it can be applied to a variety of disorders simultaneously and its manualised format makes it suitable for blended interventions. Methods and analysis The study is a multicentre, randomised, superiority, clinical trial. Participants will be 310 individuals with a diagnosis of an ED. They will be randomised to a treatment as usual (individual cognitive behavioural therapy) or a UP condition in a blended format (face-to-face individual UP +online, app-based UP). Primary outcomes will be ED diagnostic criteria and depression and anxiety symptoms. Cost efficiency of the intervention, app usability, as well as opinion and confidence in the treatment will also be evaluated. Assessment points will include baseline and 3 months, 6 months and 12 months after UP treatment. Ethics and dissemination The study has received approvals by the Ethics Research Committee of Navarra, Castellon, Euskadi, Castilla y Leon, Extremadura, Lleida and Aragon. The study is currently under an approval process by the Ethics Research Committees of all the remaining collaborating centres. Outcomes will be disseminated through publication in peer-reviewed journals and presentations at international conference meetings. 000117953 540__ $$9info:eu-repo/semantics/openAccess$$aby-nc$$uhttp://creativecommons.org/licenses/by-nc/3.0/es/ 000117953 594__ $$a3.9$$b2021 000117953 590__ $$a3.007$$b2021 000117953 592__ $$a0.982$$b2021 000117953 591__ $$aMEDICINE, GENERAL & INTERNAL$$b86 / 172 = 0.5$$c2021$$dQ2$$eT2 000117953 593__ $$aMedicine (miscellaneous)$$c2021$$dQ1 000117953 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion 000117953 700__ $$aMartinez-Garcia, Laura$$uUniversidad de Zaragoza 000117953 700__ $$0(orcid)0000-0002-2437-1207$$aPeris-Baquero, Óscar$$uUniversidad de Zaragoza 000117953 700__ $$0(orcid)0000-0001-9726-3250$$aNavarro-Haro, María Vicenta$$uUniversidad de Zaragoza 000117953 700__ $$aGonzalez-Perez, Alberto 000117953 700__ $$aSuso-Ribera, Carlos 000117953 7102_ $$14009$$2740$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Psicología Social 000117953 7102_ $$14009$$2680$$aUniversidad de Zaragoza$$bDpto. Psicología y Sociología$$cÁrea Person.Eval.Trat.Psicoló. 000117953 773__ $$g11, 12 (2021), [9 pp]$$pBMJ Open$$tBMJ Open$$x2044-6055 000117953 8564_ $$s410920$$uhttps://zaguan.unizar.es/record/117953/files/texto_completo.pdf$$yVersión publicada 000117953 8564_ $$s3260494$$uhttps://zaguan.unizar.es/record/117953/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada 000117953 909CO $$ooai:zaguan.unizar.es:117953$$particulos$$pdriver 000117953 951__ $$a2023-05-18-15:52:48 000117953 980__ $$aARTICLE